↓ Skip to main content

A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study…

Overview of attention for article published in Trials, September 2014
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
121 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial
Published in
Trials, September 2014
DOI 10.1186/1745-6215-15-367
Pubmed ID
Authors

Samal Gunatilake, Fraser JH Brims, Carole Fogg, Iain Lawrie, Nick Maskell, Karen Forbes, Najib Rahman, Steve Morris, Reuben Ogollah, Stephen Gerry, Mick Peake, Liz Darlison, Anoop J Chauhan

Abstract

Malignant pleural mesothelioma is an incurable cancer caused by exposure to asbestos. The United Kingdom has the highest death rate from mesothelioma in the world and this figure is increasing. Median survival is 8 to 12 months, and most patients have symptoms at diagnosis. The fittest patients may be offered chemotherapy with palliative intent. For patients not fit for systemic anticancer treatment, best supportive care remains the mainstay of management. A study from the United States examining advanced lung cancer showed that early specialist palliative care input improved patient health related quality of life and depression symptoms 12 weeks after diagnosis. While mesothelioma and advanced lung cancer share many symptoms and have a poor prognosis, oncology and palliative care services in the United Kingdom, and many other countries, vary considerably compared to the United States. The aim of this trial is to assess whether regular early symptom control treatment provided by palliative care specialists can improve health related quality of life in patients newly diagnosed with mesothelioma.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 121 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 120 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 21 17%
Researcher 17 14%
Student > Ph. D. Student 13 11%
Student > Bachelor 11 9%
Student > Postgraduate 7 6%
Other 21 17%
Unknown 31 26%
Readers by discipline Count As %
Medicine and Dentistry 29 24%
Nursing and Health Professions 20 17%
Psychology 9 7%
Social Sciences 4 3%
Engineering 4 3%
Other 16 13%
Unknown 39 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2015.
All research outputs
#18,967,582
of 21,321,525 outputs
Outputs from Trials
#4,864
of 5,445 outputs
Outputs of similar age
#188,045
of 224,649 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 21,321,525 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,445 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 224,649 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them